In the conflict-of-interest disclosure on page 2616, “M.L.M. is responsible for cultured thymus tissue implantation (Clinical Trials Transformation Initiative [CTTI]; RVT-802)” should read “M.L.M. is responsible for cultured thymus tissue implantation (CTTI; RVT-802).” The error has been corrected in the published article.
ERRATUM|
August 4, 2020
Bosticardo M, Pala F, Calzoni E, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020;4(12):2611-2616.
Blood Adv (2020) 4 (15): 3507.
Article history
Submitted:
July 15, 2020
Accepted:
July 15, 2020
Connected Content
Citation
Bosticardo M, Pala F, Calzoni E, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020;4(12):2611-2616.. Blood Adv 2020; 4 (15): 3507. doi: https://doi.org/10.1182/bloodadvances.2020002957
Download citation file: